|
Image-guided ultrasound ablation for precision targeting of prostate cancer
|
1R01CA230323-01
|
$580,217
|
|
BURDETTE, EVERETTE
|
ACOUSTIC MEDSYSTEMS, INC.
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Genetic and Dietary Interactions in MMR Deficient Colon Tumorigenesis
|
1R01CA222358-01A1
|
$635,306
|
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Next Generation of HPV and Cervical Cancer Research in HIV+ Women
|
1R01CA230331-01
|
$670,295
|
|
STRICKLER, HOWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Identification and targeting of pathways separating healthy stem cell aging from malignant transformation
|
1R01CA230756-01
|
$382,013
|
|
WILL, BRITTA
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Effects of Meditative Movement (Qigong/Tai Chi Easy) on Fatigued Breast Cancer Survivors
|
3R01CA182901-04S1
|
$39,254
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Novel Biomarkers for the Clinical Management of Bladder Cancer
|
1R01CA227277-01A1
|
$466,211
|
|
LOKESHWAR, VINATA
|
AUGUSTA UNIVERSITY
|
|
Improving pathologic nodal staging of resected lung cancer
|
2R01CA172253-06
|
$499,347
|
|
OSAROGIAGBON, RAYMOND
|
BAPTIST MEMORIAL HOSPITAL - TIPTON
|
|
(PQ5) Exploring the Biological Distinctions between HIV-related and Endemic Pediatric Kaposi Sarcoma in a Kaposi Sarcoma-Associated Herpesvirus-Endemic Region of Africa
|
5R21CA217137-02
|
$196,947
|
$196,947
|
EL-MALLAWANY, NADER
|
BAYLOR COLLEGE OF MEDICINE
|
|
(PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
|
1R01CA230848-01
|
$442,560
|
|
FU, LONING
|
BAYLOR COLLEGE OF MEDICINE
|
|
Risk Stratification for and Early Detection of Liver Cancer
|
1U01CA230997-01
|
$732,726
|
|
KANWAL, FASIHA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Context-Specific Functional Annotation of EGFR Mutations in Glioblastoma
|
5F32CA221015-02
|
$59,038
|
|
KONG, KATHLEEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-02S1
|
$7,156
|
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
3R01CA215452-02S1
|
$7,156
|
$3,578
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and Targeting Onocgenic MYC Enhancer Control in Pediatric Tumors
|
3R01CA215452-02S2
|
$45,800
|
$22,900
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Identifying and targeting oncogenic Myc enhancer control in pediatric tumors
|
5R01CA215452-02
|
$362,569
|
$181,284
|
LIN, CHARLES
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S1
|
$118,875
|
$1,189
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S2
|
$249,997
|
$2,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-12S3
|
$125,004
|
$1,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-12
|
$3,203,119
|
$32,031
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Targeting aberrant promoter DNA methylation for anticancer therapy
|
1R21CA229727-01
|
$182,700
|
|
SHEN, LANLAN
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Target for Chromatin Remodeler Defects in Cancer
|
1R35CA231993-01
|
$594,375
|
|
WALKER, CHERYL
|
BAYLOR COLLEGE OF MEDICINE
|
|
Dissecting the molecular and functional role of ILK in driving metastatic colonization and progression in Ewing sarcoma
|
5R03CA215940-02
|
$75,288
|
$75,288
|
YUSTEIN, JASON
|
BAYLOR COLLEGE OF MEDICINE
|
|
Stem Cell/Nanoparticle Constructs for Targeted Ovarian Cancer Therapy
|
3R01CA197359-04S1
|
$68,577
|
|
BERLIN, JACOB
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
|
7R01CA182528-06
|
$392,355
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting TET1 signaling to treat acute myeloid leukemia
|
7R01CA211614-02
|
$475,560
|
|
CHEN, JIANJUN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Precision Antibody-Based Therapy to Neutralize Epstein-Barr Virus-Associated PTLDs
|
1R21CA232275-01
|
$225,765
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
A novel VLP vaccine to prevent EBV infection and EBV - associated malignancies
|
3R21CA205106-02S1
|
$77,331
|
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-05
|
$98,360
|
$98,360
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S3
|
$865,000
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Combined breast MRI/biomarker strategies to identify aggressive biology
|
3U01CA189283-04S1
|
$190,203
|
|
SEEWALDT, VICTORIA
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Tissue-specific genetic interactions in cancer
|
1R01CA232372-01
|
$505,643
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Identification of Plasma- and Exosome-Based Protein Biomarkers for Early Detection of Pancreatic Cancer Using SOMAscan Technology
|
1R21CA218960-01A1
|
$228,375
|
|
LIBERMANN, TOWIA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression
|
1R01CA228029-01A1
|
$688,217
|
|
PERELMAN, LEV
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older
|
3R01CA181357-05S1
|
$20,788
|
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mechanisms of tumorigenesis in Brg1 mutant lung cancer
|
1R01CA216188-01A1
|
$683,713
|
|
KIM, CARLA
|
BOSTON CHILDREN'S HOSPITAL
|
|
Cancer Biology in the Zebrafish
|
2R01CA103846-16A1
|
$420,375
|
|
ZON, LEONARD
|
BOSTON CHILDREN'S HOSPITAL
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
Clinical Feasibility of Chemotherapy Monitoring for Sarcoma with Diffuse Optical Spectroscopic Imaging
|
1F31CA221074-01A1
|
$38,082
|
$38,082
|
PETERSON, HANNAH
|
BOSTON UNIVERSITY (CHARLES RIVER CAMPUS)
|
|
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
|
1R01CA222170-01A1
|
$559,846
|
|
DENIS, GERALD
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Molecular Mechanisms Regulating the Alternative Lengthening of Telomeres Pathway
|
5R01CA201446-03
|
$377,438
|
$377,438
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Functional characterization of the telomere repeat containing RNA, TERRA, in telomere maintenance
|
5R01CA214880-02
|
$237,158
|
$237,158
|
FLYNN, RACHEL
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Development of a novel Antibody Drug Conjugate for the treatment of pancreaticcancer
|
1F30CA220843-01A1
|
$49,524
|
|
GROMISCH, CHRISTOPHER
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Understanding the mechanisms of immune suppression in lymph node metastases
|
1K22CA230315-01
|
$200,880
|
|
JONES, DENNIS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Determining the roles of the Hippo pathway kinases LATS1 and LATS2 in mammary gland homeostasis and disease
|
1F31CA232683-01
|
$44,524
|
|
KERN, JOSEPH
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Gaining Metabolic Insight in Older Men undergoing Androgen Deprivation Therapy for Prostate Cancer
|
1R01CA226211-01A1
|
$485,064
|
|
BASARIA, SHEHZAD
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Developing a translational pipeline for NF1-mutant malignancies
|
5U01CA202943-03
|
$235,046
|
$235,046
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis and Treatment of NUT-Midline Carcinoma
|
2R01CA124633-11A1
|
$340,100
|
|
FRENCH, CHRISTOPHER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
In Situ characterization and manipulation of tumor immune cell metabolomics using implantable microdevices
|
1R01CA223150-01A1
|
$366,134
|
|
JONAS, OLIVER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Genetic and Biochemical Studies of KSHV LANA
|
5R01CA082036-19
|
$228,408
|
$228,408
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
Total relevant funding to Sarcoma for this search: $154,139,201
|